NCT04159116 is a NA clinical trial of Prophylactic suctioning when clinically indicated in Laryngospasm, sponsored by Envision Healthcare Scientific Intelligence, Inc..

Who is sponsoring NCT04159116?

NCT04159116 is sponsored by Envision Healthcare Scientific Intelligence, Inc..

What drugs are being tested in NCT04159116?

Interventions in NCT04159116: Prophylactic suctioning when clinically indicated.

What condition does NCT04159116 study?

NCT04159116 studies Laryngospasm, Hypoxemia.

Is NCT04159116 still recruiting?

NCT04159116 is currently completed. Last updated 17 March 2021.

Last reviewed 2021-03-17 · How we verify

NCT04159116

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention and Treatment of Laryngospasm and Hypoxemia Based on Risk Factors in Adult Outpatients Undergoing EGD

Completed NA Last updated 17 March 2021

What this trial tests

NA trial testing Prophylactic suctioning when clinically indicated in Laryngospasm in 57 participants. Completed in 19 March 2020.

Timeline

4 November 2019

Primary endpoint
19 March 2020

19 March 2020

Quick facts

Lead sponsor	Envision Healthcare Scientific Intelligence, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	57
Start date	4 November 2019
Primary completion	19 March 2020
Estimated completion	19 March 2020
Sites	1 location across United States

Drugs / interventions tested

Prophylactic suctioning when clinically indicated

Conditions studied

Laryngospasm — all drugs for Laryngospasm →
Hypoxemia — all drugs for Hypoxemia →

Sponsor

Envision Healthcare Scientific Intelligence, Inc.

Who can join

18 and older, any sex, with Laryngospasm or Hypoxemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to identify patient and provider-chosen factors that put patients at risk for the development of hypoxemia (oxygen saturation \< 90% for 5 seconds) during endoscopy and to use this knowledge to develop a treatment protocol for specific causes of hypoxemia in adult esophagogastroduodenoscopy outpatients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Envision Healthcare Scientific Intelligence, Inc. trials

Trials by the same sponsor.

NCT03015649 — Long Term Use of SAVI SCOUT: Pilot Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04159116 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Envision Healthcare Scientific Intelligence, Inc.
Last refreshed: 17 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04159116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing